MyT: a Next-Generation TCR and Epitope Discovery Platform to Design TCR-T Therapies of High Efficacy and Safety

Time: 2:30 pm
day: Day Two


• MyT mouse lines carrying human TCRs and multiple HLAs to avoid central tolerance and identify TCRs of high affinity and specificity
• Unbiased in vivo epitope discovery engine to identify naturally processed epitopes across multiple HLA types
• TK-8001, a MAGE-A1 targeting TCR-T therapy for solid tumors